Faculty profile

Darren Lau

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Darren Lau

Researcher

Medicine

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
33 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Continuous Glucose Monitoring Cost-Effectiveness Diabetes Mellitus, Type 2 Digital Health Economic Evaluation Randomized Controlled Trial Knowledge Mobilization Knowledge Translation

Latest papers

The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort.
Diabetes, obesity & metabolism · 2026 · senior author
Perioperative hyperglycemia and postoperative outcomes: a retrospective cohort study.
Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2026
In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than oral semaglutide at 52 wk.
Annals of internal medicine · 2026 · first author

All 50 publications

Latest funding

Sustaining the Benefits of Continuous Glucose Monitoring (CGM) in Adults with Type 2 Diabetes Not on Insulin: A Randomized Controlled Trial (SUSTAIN-CGM)
CIHR · 2025 · Nominated PI
$1,185,752
Advisory groUp of adult patients and caRegivers Of childRen and youth with type 1 diAbetes mellitus (AURORA) Study
CIHR · 2024 · Principal investigator
$125,000
The DIabeteS and Cancer OUtcomes in a Real-world SEtting (DISCOURSE) Study
CIHR · 2023 · Co-investigator
$462,824

All 3 grants and awards

50 publications.

The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort.

Zhang JR, Yeung RO, Manca DP, Singh P, Olu-Jordan I, Perry T, Rahim G, Hagen EM, Lau D

Diabetes, obesity & metabolism2026Senior author

DOI: 10.1111/dom.71048 PMID: 42381345

Perioperative hyperglycemia and postoperative outcomes: a retrospective cohort study.

Hammal F, Lau D, Green J, Ruzycki S, Dillane D

Canadian journal of anaesthesia = Journal canadien d'anesthesie2026

DOI: 10.1007/s12630-026-03157-9 PMID: 42481888

In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than oral semaglutide at 52 wk.

Lau D, ACP Journal Club Editorial Team at McMaster University

Annals of internal medicine2026First author

DOI: 10.7326/annals-26-01781-jc PMID: 42224699

Impact of COVID-19-related data drift on machine-learning prognostic models predicting 30-day opioid-related emergency department visits, hospitalisation or mortality: a population-level administrative data study in Alberta, Canada.

Sharma V, Li W, Joon T, Dubois C, Lau D, Jess E, Lindeman C, Kain NA, Ye M, Semenchuk M, Eurich DT, Samanani S

BMJ open2026

DOI: 10.1136/bmjopen-2025-103318 PMID: 42167940

Resource Use Following Revascularization for Multivessel Coronary Artery Disease.

El-Andari R, Kang J, Fialka N, Bozso SJ, Hong Y, Klarenbach S, Lau D, Nagendran J, Nagendran J

Journal of the American Heart Association2026

DOI: 10.1161/jaha.126.049340 PMID: 42017326

'It's not just diabetes': implementation enablers and barriers of an indigenous-focused virtual diabetes care clinic using the Consolidated Framework for Implementation Research (CFIR) - a qualitative assessment.

Swampy K, Eurich DT, Meneen K, Samanani S, Singh P, Wozniak LA, Padwal RS, Lau D

BMJ open2026Senior author

DOI: 10.1136/bmjopen-2025-107266 PMID: 41997705

Practice Variation in Prescribing SGLT2-Inhibitors: A Population-Based Analysis from Alberta, Canada.

Kanji R, Chew DS, Au F, Campbell DJT, Lau D, Beall RF, Ronksley PE, Manns B, Quinn AE

CJC open2026

DOI: 10.1016/j.cjco.2025.11.015 PMID: 41836121

The Effects of Continuous Glucose Monitoring on Patient-reported Outcomes in Adults With Non-Insulin-dependent Type 2 Diabetes: A Randomized Controlled Trial.

Olu-Jordan I, Singh P, Zhang JR, Yeung RO, Manca DP, Perry T, Rahim G, Hagen E, Lau D

Canadian journal of diabetes2026Senior author

DOI: 10.1016/j.jcjd.2025.10.174 PMID: 41161400

The Real‐World Effectiveness of Human Immunodeficiency Virus Pre‐Exposure Prophylaxis in Adults in Alberta, Canada: A Retrospective Population‐Based Cohort Study

May ER, Lin M, Turvey SL, Chew DS, Tonelli M, Klarenbach S, Pannu N, Christie E, Thompson S, Bello A

Canadian Journal of Infectious Diseases and Medical Microbiology2025

DOI: 10.1155/cjid/9340622

Upstream Delivery of Routine Chronic Kidney Disease Screening for Individuals With Diabetes Is an Impediment to Realizing Cardio-Kidney Care.

Lau D

Canadian journal of diabetes2025First author

DOI: 10.1016/j.jcjd.2025.12.008 PMID: 41456922

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Continuous Glucose Monitoring Dear Professor Lau, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Sustaining the Benefits of Continuous Glucose Monitoring (CGM) in Adults with Type 2 Diabetes Not on Insulin: A Randomized Controlled Trial (SUSTAIN-CGM)" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Darren Lau

Research

Latest papers

Latest funding

The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12&#x2009;Months: An Observational Follow-Up of a Randomized Trial Cohort.

Perioperative hyperglycemia and postoperative outcomes: a retrospective cohort study.

In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than oral semaglutide at 52 wk.

Impact of COVID-19-related data drift on machine-learning prognostic models predicting 30-day opioid-related emergency department visits, hospitalisation or mortality: a population-level administrative data study in Alberta, Canada.

Resource Use Following Revascularization for Multivessel Coronary Artery Disease.

'It's not just diabetes': implementation enablers and barriers of an indigenous-focused virtual diabetes care clinic using the Consolidated Framework for Implementation Research (CFIR) - a qualitative assessment.

Practice Variation in Prescribing SGLT2-Inhibitors: A Population-Based Analysis from Alberta, Canada.

The Effects of Continuous Glucose Monitoring on Patient-reported Outcomes in Adults With Non-Insulin-dependent Type 2 Diabetes: A Randomized Controlled Trial.

The Real‐World Effectiveness of Human Immunodeficiency Virus Pre‐Exposure Prophylaxis in Adults in Alberta, Canada: A Retrospective Population‐Based Cohort Study

Upstream Delivery of Routine Chronic Kidney Disease Screening for Individuals With Diabetes Is an Impediment to Realizing Cardio-Kidney Care.

Sustaining the Benefits of Continuous Glucose Monitoring (CGM) in Adults with Type 2 Diabetes Not on Insulin: A Randomized Controlled Trial (SUSTAIN-CGM)

Advisory groUp of adult patients and caRegivers Of childRen and youth with type 1 diAbetes mellitus (AURORA) Study

The DIabeteS and Cancer OUtcomes in a Real-world SEtting (DISCOURSE) Study

Frequent collaborators

Scott Klarenbach

Salim Samanani

Raj Padwal

Peter Senior

Neesh Pannu

Sonia Butalia

David Collister

Alan Katz

David Collister

Paul Ronksley

Sonia Butalia

Raynell Lang

Lisa Dolovich

Stephanie Thompson

Reed Beall

Devidas Menon

Michelle Greiver

Amity Quinn

Elissa Rennert-May

Raynell Lang

Ross Tsuyuki

Paul Ronksley

Braden Manns

The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort.